Skip to main content
. 2019 Jan 9;8:557. doi: 10.3389/fonc.2018.00557

Figure 5.

Figure 5

Forest plot of meta-analysis of the objective response rate (ORR) showing comparison of Next generation agents to crizotinib in ALK positive NSCLC.